Eton Pharmaceuticals raises $7.0M in registered direct offering of 583,334 shares at $12.00/share

Eton Pharmaceuticals, Inc.

Entered Securities Purchase Agreement on Dec 10, 2024 with an institutional investor.
Gross proceeds approximately $7.0 million from sale of 583,334 shares at $12.00 per share.
No placement agent; shares offered under effective S-3 registration statement.
Proceeds intended for funding acquisition opportunities for products or product candidates.
Shares will be issued free of restrictive legends.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.